Inve US ▾
AMAME

AMETEK (AME) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Industrials· Aug 4, 2026

Source: earnings call transcript

AMETEK delivered an outstanding second quarter, exceeding expectations with record sales, orders, and earnings, driven by broad-based organic growth and robust margin expansion. The company's strategic portfolio alignment with secular growth drivers like AI infrastructure, defense modernization, and medtech is fueling strong demand. Management raised full-year guidance, reflecting confidence in continued performance and a strong pipeline of acquisition opportunities.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

AME operating KPIs by quarter

AME operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Sep 2025 Q3 FY25 Dec 2025 Q4 FY25 Mar 2026 Q1 FY26This call Jun 2026 Q2 FY26Change vs prior quarter
Backlog
$3.4B with positive organic growth across both our EIG and EMG segments, and we ended the quarter with a strong backlog of $3.4 billion. Source: earnings call transcript
$3.47B Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
$3.54B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$3.58B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$3.87B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
—+8.1%
Book-to-bill ratio —
1.04 ratio Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
—
1.02 ratio So it was broad-based, and there was a similar pattern from Q3 and the book-to-bill of AMETEK was 1.02, and it was pretty broad-based. Source: earnings call transcript
—
1.12 ratio Our backlog was now $4.11 billion, up about 21% from the end of the year, and we had a positive book-to-bill of 1.12 in the quarter, both groups positive -- and we also are executing very well. Source: earnings call transcript
—
Vitality Index —
26% Our vitality index, which measures the sales of new products introduced in the past 3 years was a strong 26% in the first quarter. Source: earnings call transcript
26% The tangible results of this focus are clear with our third quarter Vitality Index, a strong 26%. Source: earnings call transcript
30% In the fourth quarter, our Vitality Index, which measures sales of new products introduced over the last 3 years was an outstanding 30%. Source: earnings call transcript
25% In the first quarter, our vitality index which measures sales of new products introduced over the last 3 years was an outstanding 25%. Source: earnings call transcript
25% In the second quarter, our new product vitality was a strong 25%. Source: earnings call transcript
0 pt
Orders ——
$1.97B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$2B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$2.2B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
$2.3B Overall orders were a record $2.3 billion, up 28% versus the prior year, with organic orders up sharply at 25%, being to a record backlog of $4.1 billion. Source: earnings call transcript
+4.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.